Morphological and Metabolic Changes of Dorsal Root Ganglion and Sympathetic Ganglion in Patients With Postherpetic Neuralgia on MRI

Sponsor
Huazhong University of Science and Technology (Other)
Overall Status
Recruiting
CT.gov ID
NCT04880408
Collaborator
(none)
30
1
21
1.4

Study Details

Study Description

Brief Summary

Object: Postherpetic neuralgia (PHN) is pain that persists for 1-3 months after herpes zoster onset. It is the most common complication of herpes zoster and occurs in 15-40% of patients with herpes zoster. PHN has been suggested to be related with the lesion of doral root ganglion (DRG). However, the studies are almost limited to autopsies and animals , and the mechanism of PHN is still unclear. This study was conducted to investigate morphological and metabolic changes of DRG and sympathetic ganglion in patients with postherpetic neuralgia on MRI. Method: 30 patients diagnosed as PHN were recruited. The volume and fractional anisotropy of DRG of lesion dermatomes were measured under MRI, and compared with contralateral and adjacent DRG. The volume and fractional anisotropy of sympathetic ganglion of lesion dermatomes were also measured under MRI, and compared with contralateral and adjacent sympathetic ganglion.Then, the association between clinical phenotypes and DRG changes were analyzed.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients with the following conditions were excluded: psychiatric diseases or communication disorders; contraindications to MRI;DRG radiofrequency therapy, spinal cord electrical stimulation and other direct intervention treatments for DRG were performed before examination.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Morphological and Metabolic Changes of Dorsal Root Ganglion and Sympathetic Ganglion in Patients With Postherpetic Neuralgia on MRI
    Actual Study Start Date :
    Jan 1, 2021
    Anticipated Primary Completion Date :
    Oct 1, 2022
    Anticipated Study Completion Date :
    Oct 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. To compare the volume and fractional anisotropy of DRG between lesion dermatomes and contralateral dermatomes [1 year]

      DRGs of lesion and contralateral dermatomes were scanned under MRI. Then, the valume (the maximum cross-section area ×layers/2) and fractional anisotropy of DRGs were measured with RadiAnt DICOM Viewer, and the comparison was made between lesion and contralateral DRG.

    Secondary Outcome Measures

    1. To compare the volume and fractional anisotropy of sympathetic ganglion between lesion dermatomes and contralateral dermatomes. [1 year]

      as primary outcome measure, sympathetic ganglions of lesion and contralateral dermatomes were scanned under MRI. Then, the valume (the maximum cross-section area ×layers/2) and fractional anisotropy of sympathetic ganglions were measured with RadiAnt DICOM Viewer, and the comparison was made between lesion and contralateral sympathetic ganglions.

    2. To compare the volume and fractional anisotropy of DRG between lesion dermatomes and adjacent dermatomes. [1 year]

      DRGs of lesion and adjacent dermatomes were scanned under MRI. Then, the valume (the maximum cross-section area ×layers/2) and fractional anisotropy of DRGs were measured with RadiAnt DICOM Viewer, and the comparison was made between lesion and adjacent DRG.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • aged more than 18 herpes zoster in cervical, thoracic,lumbar or sacral regions agree to participate to the research
    Exclusion Criteria:
    • can not cooperate to MRI for mental disease contraindication for MRI treatments for DRG such as radiaofrequency therapy, spinal cord electircal stimulation were performed before examination. disagree to participate to the research

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei China 430030

    Sponsors and Collaborators

    • Huazhong University of Science and Technology

    Investigators

    • Principal Investigator: Xianwei Zhang, Doctor, Huazhong University of Science and Technology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Xianwei Zhang,MD, Clinical Professor, Huazhong University of Science and Technology
    ClinicalTrials.gov Identifier:
    NCT04880408
    Other Study ID Numbers:
    • herpes zoster
    First Posted:
    May 10, 2021
    Last Update Posted:
    May 10, 2021
    Last Verified:
    May 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Xianwei Zhang,MD, Clinical Professor, Huazhong University of Science and Technology
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 10, 2021